China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%
China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit. Previously, TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hit the daily limit, while Huaren Health, Baheal Medical, SYPM, INNOSTIC, HRPC, and other stocks rose more than 5%.